Unlike PDE-5 inhibitors, PT-141 does not depend primarily on peripheral blood flow modulation
For example, certain GLP1R variants may suggest stronger baseline sensitivity to GLP-1 receptor activation, while FTO variants can indicate predisposition to metabolic resistance
extreme tiredness (fatigue) shortness of breath chest pain or tightness problems with memory and concentration (brain fog) difficulty sleeping (insomnia) heart palpitations dizziness pins and needles joint pain depression and anxiety tinnitus, earaches feeling sick, diarrhoea, stomach aches, loss of appetite a high temperature, cough, headaches, sore throat, changes to sense of smell or taste rashes Ah
Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals